The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
FC DAC 1904 Dunaszerdahely and BioTechUSA enter into partnership
BioTechUSA’s sports sponsorship portfolio has been expanded with another professional…
Read more >Sport as a strategic brand experience
Today sport is way more than just a sponsorship platform:…
Read more >BioTechUSA and FC Barcelona: partnership reaches new level with Pedri and new product
The BioTechUSA Group has been FC Barcelona’s global nutritional supplement…
Read more >Related news
Producer prices in the euro area and the European Union decreased month-on-month and increased year-on-year in April
Producer prices in the eurozone and the European Union (EU)…
Read more >The 2024 FMCG Retailer Ranking is out now
Everything remains the same: Lidl, SPAR and Tesco are the…
Read more >